146 related articles for article (PubMed ID: 31857694)
1. Mechanism for the lethal effect of enterovirus A71 intracerebral injection in neonatal mice.
Feng M; Liao Y; Gao Y; Jiang G; Wang L; Zhang Y; Fan S; Xu X; Li Q
Lab Invest; 2020 Apr; 100(4):596-605. PubMed ID: 31857694
[TBL] [Abstract][Full Text] [Related]
2. A Mouse Model for Infection with Enterovirus A71 in Small Extracellular Vesicles.
Gu J; Wu J; Cao Y; Zou X; Jia X; Yin Y; Shen L; Fang D; Mao L
mSphere; 2020 Jul; 5(4):. PubMed ID: 32611697
[TBL] [Abstract][Full Text] [Related]
3. [Establishment of a Model of Infection by Enterovirus 71 in ICR Mice].
Dong Z; Zhang Z; Yang L; Li D; Shi W
Bing Du Xue Bao; 2016 Nov; 32(6):671-82. PubMed ID: 30004196
[TBL] [Abstract][Full Text] [Related]
4. Enterovirus A71 Infection Activates Human Immune Responses and Induces Pathological Changes in Humanized Mice.
Ke Y; Liu WN; Her Z; Liu M; Tan SY; Tan YW; Chan XY; Fan Y; Huang EK; Chen H; En Chang KT; Chan JKY; Hann Chu JJ; Chen Q
J Virol; 2019 Feb; 93(3):. PubMed ID: 30429352
[TBL] [Abstract][Full Text] [Related]
5. Clinically isolated enterovirus A71 subgenogroup C4 strain with lethal pathogenicity in 14-day-old mice and the application as an EV-A71 mouse infection model.
Xu Y; Ma S; Zhu L; Huang Z; Chen L; Xu Y; Yin H; Peng T; Wang Y
Antiviral Res; 2017 Jan; 137():67-75. PubMed ID: 27864074
[TBL] [Abstract][Full Text] [Related]
6. Enterovirus A71 Induces Neurological Diseases and Dynamic Variants in Oral Infection of Human SCARB2-Transgenic Weaned Mice.
Lin JY; Weng KF; Chang CK; Gong YN; Huang GJ; Lee HL; Chen YC; Huang CC; Lu JY; Huang PN; Chiang HJ; Chen CM; Shih SR
J Virol; 2021 Oct; 95(21):e0089721. PubMed ID: 34379497
[TBL] [Abstract][Full Text] [Related]
7. Murine models of neonatal susceptibility to a clinical strain of enterovirus A71.
Xie J; Hu X; Li H; Zhu H; Lin W; Li L; Wang J; Song H; Jia L
Virus Res; 2023 Jan; 324():199038. PubMed ID: 36599394
[TBL] [Abstract][Full Text] [Related]
8. A Selective Bottleneck Shapes the Evolutionary Mutant Spectra of Enterovirus A71 during Viral Dissemination in Humans.
Huang SW; Huang YH; Tsai HP; Kuo PH; Wang SM; Liu CC; Wang JR
J Virol; 2017 Dec; 91(23):. PubMed ID: 28931688
[TBL] [Abstract][Full Text] [Related]
9. Immune responses against enterovirus A71 infection: Implications for vaccine success.
Aw-Yong KL; NikNadia NMN; Tan CW; Sam IC; Chan YF
Rev Med Virol; 2019 Sep; 29(5):e2073. PubMed ID: 31369184
[TBL] [Abstract][Full Text] [Related]
10. Mouse Scarb2 Modulates EV-A71 Pathogenicity in Neonatal Mice.
Miwatashi W; Ishida M; Takashino A; Kobayashi K; Yamaguchi M; Shitara H; Koike S
J Virol; 2022 Aug; 96(15):e0056122. PubMed ID: 35867561
[TBL] [Abstract][Full Text] [Related]
11. A Polysaccharide Purified From
Lin YL; Shih C; Cheng PY; Chin CL; Liou AT; Lee PY; Chiang BL
Front Immunol; 2020; 11():561758. PubMed ID: 33117346
[TBL] [Abstract][Full Text] [Related]
12. Severity of enterovirus A71 infection in a human SCARB2 knock-in mouse model is dependent on infectious strain and route.
Zhu J; Chen N; Zhou S; Zheng K; Sun L; Zhang Y; Cao L; Zhang X; Xiang Q; Chen Z; Wang C; Fan C; He Q
Emerg Microbes Infect; 2018 Dec; 7(1):205. PubMed ID: 30518755
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanism of L-SP40 peptide and in vivo efficacy against EV-A71 in neonatal mice.
Lalani S; Tan SH; Tan KO; Lim HX; Ong KC; Wong KT; Poh CL
Life Sci; 2021 Dec; 287():120097. PubMed ID: 34715144
[TBL] [Abstract][Full Text] [Related]
14. Broad protection with an inactivated vaccine against primary-isolated lethal enterovirus 71 infection in newborn mice.
Chang J; Li J; Liu X; Liu G; Yang J; Wei W; Zhang W; Yu XF
BMC Microbiol; 2015 Jul; 15():139. PubMed ID: 26169371
[TBL] [Abstract][Full Text] [Related]
15. Intra-host emergence of an enterovirus A71 variant with enhanced PSGL1 usage and neurovirulence.
Sun L; Tijsma A; Mirabelli C; Baggen J; Wahedi M; Franco D; De Palma A; Leyssen P; Verbeken E; van Kuppeveld FJM; Neyts J; Thibaut HJ
Emerg Microbes Infect; 2019; 8(1):1076-1085. PubMed ID: 31339457
[TBL] [Abstract][Full Text] [Related]
16. Enterovirus A71 VP1 Variation A289T Decreases the Central Nervous System Infectivity via Attenuation of Interactions between VP1 and Vimentin In Vitro and In Vivo.
Zhu H; Cao Y; Su W; Huang S; Lu W; Zhou Y; Gao J; Zhao W; Zhang B; Wu X
Viruses; 2019 May; 11(5):. PubMed ID: 31121933
[TBL] [Abstract][Full Text] [Related]
17. Suppression of interleukin-6 increases enterovirus A71 lethality in mice.
Wang LC; Yao HW; Chang CF; Wang SW; Wang SM; Chen SH
J Biomed Sci; 2017 Dec; 24(1):94. PubMed ID: 29233145
[TBL] [Abstract][Full Text] [Related]
18. VP1 codon deoptimization and high-fidelity substitutions in 3D polymerase as potential vaccine strategies for eliciting immune responses against enterovirus A71.
Hsieh W-S; Chao C-H; Shen C-Y; Cheng D; Huang S-W; Wang Y-F; Chen C-C; Chen S-H; Hsu L-J; Wang J-R
J Virol; 2024 Jan; 98(1):e0155823. PubMed ID: 38174926
[TBL] [Abstract][Full Text] [Related]
19. A Novel Attenuated Enterovirus A71 Mutant with VP1-V238A,K244R Exhibits Reduced Efficiency of Cell Entry/Exit and Augmented Binding Affinity to Sulfated Glycans.
Meng T; Wong SM; Chua KB
J Virol; 2021 Oct; 95(22):e0105521. PubMed ID: 34468173
[TBL] [Abstract][Full Text] [Related]
20. Electrostatic interactions at the five-fold axis alter heparin-binding phenotype and drive enterovirus A71 virulence in mice.
Tee HK; Tan CW; Yogarajah T; Lee MHP; Chai HJ; Hanapi NA; Yusof SR; Ong KC; Lee VS; Sam IC; Chan YF
PLoS Pathog; 2019 Nov; 15(11):e1007863. PubMed ID: 31730673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
